Nalaganje...
Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer
Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2022-06-01
|
| Serija: | American Journal of Ophthalmology Case Reports |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S2451993622002055 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|